Market Data 
Markets
Replies to post #208133 on Biotech Values
01/27/17 10:27 AM
Dr. Liang's mutually agreed separation from the Company comes following the completion of an independent investigation overseen by the Audit Committee that revealed Dr. Liang had not acted in accordance with the Company's Board Approval Process Policy and Code of Ethics and Conduct in connection with certain Board approval procedures for third party contracts.
AI
